Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

University of California identifies new EGFR inhibitors

Oct. 7, 2020

Anlotinib plus pemetrexed beneficial in platinum-resistant epithelial ovarian cancer

Oct. 7, 2020

University of Maryland synthesizes new Mcl-1 and Bcl-2 dual inhibitors

Oct. 7, 2020

Chiba Prefecture patents new compounds targeting mitochondrial DNA mutations

Oct. 7, 2020

Myelin regulatory factor helps out pancreatic cancer cells

Oct. 7, 2020

Phase I data for LXH-254 plus LTT-462 in patients with KRAS- or BRAF-mutant NSCLC

Oct. 6, 2020

miRagen to discontinue internal development of cobomarsen for CTCL

Oct. 6, 2020

PALLAS: palbociclib not beneficial in early breast cancer treated with endocrine therapy

Oct. 6, 2020

Pralsetinib shows promising activity in RET-mutant MTC in the phase I/II ARROW trial

Oct. 6, 2020

NuvoBio patents N-lysine methyltransferase KMT5A inhibitors

Oct. 6, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...